
-
Brazil binman finds newborn baby on garbage route
-
US senator smashes record with marathon anti-Trump speech
-
Trump advisor Waltz faces new pressure over Gmail usage
-
Niger junta frees ministers of overthrown government
-
Trump set to unleash 'Liberation Day' tariffs
-
Boeing chief to acknowledge 'serious missteps' at US Senate hearing
-
Real Madrid hold Real Sociedad in eight-goal thriller to reach Copa del Rey final
-
Nuno salutes 'special' Elanga after stunning strike fires Forest
-
PSG survive scare against Dunkerque to reach French Cup final
-
Sundowns edge Esperance as crowd violence mars quarter-final
-
Nottingham Forest beat Man Utd, Saka scores on Arsenal return
-
Elanga wonder-goal sinks Man Utd as Forest eye Champions League berth
-
Stock markets mostly advance ahead of Trump tariffs deadline
-
US movie theaters urge 45-day 'baseline' before films hit streaming
-
Saka scores on return as Arsenal beat Fulham
-
Third-division Bielefeld shock holders Leverkusen in German Cup
-
Ball-blasting 'Torpedo bats' making waves across MLB opening weekend
-
Newsmax shares surge more than 2,000% in days after IPO
-
Thousands of Hungarians protest against Pride ban law
-
GM leads first quarter US auto sales as tariffs loom
-
Tesla sales tumble in Europe in the first quarter
-
No 'eye for an eye' approach to US tariffs: Mexico
-
NFL club owners back dynamic kickoffs, delay tush push vote
-
Trump 'perfecting' new tariffs as nervous world braces
-
Trump nominee says to press UK on Israel arms
-
French court says Le Pen appeal ruling could come before presidential vote
-
The battle to control assets behind Bosnia crisis
-
Prabhsimran powers Punjab to IPL win over Lucknow
-
Mass layoffs targeting 10,000 jobs hit US health agencies
-
Tiger's April Foolishness: plan to play Masters just a joke
-
Myanmar quake toll passes 2,700, nation halts to honour victims
-
Turkish fans, artists urge Muse to cancel Istanbul gig
-
US seeks death penalty for accused killer of insurance CEO
-
UK govt moves to block sentencing guidelines for minority defendants
-
Trump puts world on edge as 'Liberation Day' tariffs loom
-
Swedish journalist jailed in Turkey kept 'isolated': employer
-
Stock markets advance ahead of Trump tariffs deadline
-
Gulf between Everton and Liverpool has never been bigger, says Moyes
-
Finland to withdraw from anti-personnel mine ban treaty
-
UK vows £20 million to boost drone and 'flying taxi' services
-
Ford's US auto sales dip in first quarter as tariffs loom
-
Digging for box office gold, 'A Minecraft Movie' hits cinemas
-
Southampton boss Juric desperate to avoid Premier League 'worst team' tag
-
Thailand rescue dogs double as emotional support
-
Five takeaways from Marine Le Pen verdict
-
Stock markets split ahead of Trump tariffs deadline
-
Turkish fans, artists urge Muse to cancel Istanbul gig over protest dispute
-
Former captain Edwards named new England women's cricket coach
-
Haaland ruled out for up to seven weeks: Man City boss Guardiola
-
UK Supreme Court opens car loans hearing as banks risk huge bill

Seventh person likely 'cured' of HIV, doctors announce
A 60-year-old German man is likely the seventh person to be effectively cured from HIV after receiving a stem cell transplant, doctors announced on Thursday.
The painful and risky procedure is for people who have both HIV and aggressive leukaemia, so is not an option for almost all of the nearly 40 million people living with the deadly virus across the world.
The German man, whose wished to remain anonymous, was dubbed the "next Berlin patient".
The original Berlin patient, Timothy Ray Brown, was the first person declared cured of HIV back in 2008. Brown died from cancer in 2020.
The second man from Berlin to achieve long-term HIV remission was announced ahead of the 25th International AIDS Conference being held in the German city of Munich next week.
He was first diagnosed with HIV in 2009, according to the research abstract being presented at the conference.
The man received a bone marrow transplant for his leukaemia in 2015. The procedure, which has a 10 percent risk of death, essentially replaces a person's immune system.
Then he stopped taking anti-retroviral drugs -- which reduce the amount of HIV in the blood -- in late 2018.
Nearly six years later, he appears to be both HIV and cancer free, the medical researchers said.
Christian Gaebler, a doctor-researcher at Berlin's Charite university hospital treating the patient, told AFP that the team cannot be "absolutely certain" every last trace of HIV has been eradicated.
But "the patient's case is highly suggestive of an HIV cure," Gaebler added. "He feels well and is enthusiastic about contributing to our research efforts."
- 'Promising' for wider cure -
International AIDS Society President Sharon Lewin said researchers hesitate to use the word "cure" because it is not clear how long they need to follow up such cases.
But more than five years in remission means the man "would be close" to being considered cured, she told a press conference.
There is an important difference between the man's case and the other HIV patients who have reached long-term remission, she said.
All but one of the other patients received stem cells from donors with a rare mutation in which part of their CCR5 gene was missing, blocking HIV from entering their body's cells.
Those donors had inherited two copies of the mutated CCR5 gene -- one from each parent -- making them "essentially immune" to HIV, Lewin said.
But the new Berlin patient is the first to have received stem cells from a donor who had inherited only one copy of the mutated gene.
Around 15 percent of people from European origin have one mutated copy, compared to one percent for both.
Researchers hope the latest success means there will be a much larger potential donor pool in the future.
The new case is also "promising" for the wider search for an HIV cure that works for all patients, Lewin said.
This is "because it suggests that you don't actually have to get rid of every single piece of CCR5 for gene therapy to work," she added.
The Geneva patient, whose case was announced at last year's AIDS conference, is the other exception among the seven. He received a transplant from a donor without any CCR5 mutations -- yet still achieved long-term remission.
This showed that the effectiveness of the procedure was not just down to the CCR5 gene, Lewin said.
Ch.Havering--AMWN